Opens in a new tab

Lepu Medical (Europe) Cooperatief U.A. v Occlutech (CoA, 18 August 2026)

Date18 August 2026
CourtCoA
DivisionLuxembourg (LU)
Type of actionAppeal
Case number(s)UPC_CoA_87/2026
Registry referenceUPC-COA-0000087/2026
PartiesLepu Medical (Europe) Cooperatief U.A., Lepu Medcial Technology (Bejing) Co., Ltd. v. Occlutech GmbH

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

In a final order of 17 August 2026 (UPC_CoA_87/2026), the Court of Appeal dismisses the Lepu companies’ appeal against the Hamburg Local Division’s order of 20 May 2026, which had declared EUR 58,800 in penalty payments forfeited for non-compliance with a provisional injunction granted to Occlutech on EP 2 387 951. For practitioners, the order sets out what is expected of an injunction debtor online: geo-blocking the purchase option is not enough, since offering is a separate act, and the debtor answers for the third-party platforms it supplies.

Facts and procedure

By order of 21 October 2025, the Hamburg Local Division prohibited the Lepu companies from offering, placing on the market, using, importing or storing the MemoCarna ASD and MemoCarna VSD devices in Germany, France, Italy, the Netherlands and Ireland, subject to penalty payments. Their appeal against that order was withdrawn. On Occlutech’s application of 2 March 2026, the Local Division declared EUR 58,800 forfeited, set a penalty of up to EUR 1,500 per day for further non-compliance and granted leave to appeal (UPC_CFI_553/2025). The Court of Appeal refused suspensive effect on 10 June 2026 and decided on the written pleadings. Lepu sought a reduction of the penalty to no more than EUR 20,000.

The applicable law

Art. 82(4) UPCA and Rule 354.4 RoP allow penalty payments to be declared forfeited for non-compliance. The Court may depart from the amounts set for reasons of proportionality, and the debtor bears the burden of proving full and timely compliance (paragraph 12). Offering and placing on the market are independent acts under Art. 25 UPCA (paragraph 14).

Question

Has an injunction debtor that blocked online purchases, but left offers on its website and on a third-party trade platform, complied with the injunction, and is the amount forfeited proportionate?

Decision

The Court finds the appeal admissible but unfounded (paragraph 10). The debtor must supervise third parties to which it assigns tasks and is responsible for a marketing platform it supplies with content (paragraph 13). Geo-blocking the purchase option is insufficient, as offering was prohibited in its own right (paragraph 14). The disclaimer on Lepu’s Dutch website having disappeared in an update of 2 December 2025, the devices were offered there for 91 days, and an « administrative oversight » does not show that compliance was impossible (paragraphs 15 and 17).

The absence of sales or harm is irrelevant, as offering covers making a product available so that others may propose to acquire it, and penalty payments, paid to the Court, are both coercive and punitive (paragraphs 18 and 19). The German-language MedicalExpo listing, confirmed by a key account manager, was an offer at least in Germany (paragraphs 23 to 25). Proportionality had already been taken into account by the Local Division, which stayed well below the maximum (paragraph 27). Lepu bears the costs of the appeal, including the application for suspensive effect (paragraph 31).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 25, 34, 76 and 82(4)
Rules of Procedure
Rules 118.8, 211.5, 354.3 and 354.4
Case law cited
Sibio v Abbott, Court of Appeal, 19 August 2024, Kodak v Fujifilm, Court of Appeal, 14 October 2025, Belkin v Philips, Court of Appeal, 3 October 2025, Belkin v Philips, Court of Appeal, 30 May 2025

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: UPC Court of Appeal.

Dhenne Avocats blog: UPC Appeals: What the Numbers Show.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CoA_87/2026 official number

Follow this case

First instance cited in the decision: UPC_CFI_553/2025

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 21 October 2025 Occlutech v Lepu Medical Technology (Beijing) (CFI, 21 October 2025) Application for provisional measures · UPC_CFI_553/2025

    La division fait interdiction aux sociétés Lepu de commercialiser les dispositifs MemoCarna ASD et VSD dans cinq États, sous astreinte, la validité et la contrefaçon étant suffisamment certaines et aucune garantie n'étant exigée.

  2. 20 May 2026 Occlutech v Lepu Medical (Europe) Cooperatief (CFI, 20 May 2026) Application for provisional measures · UPC_CFI_553/2025

    Les défenderesses doivent verser 58 800 euros pour manquement à l'injonction du 21 octobre 2025, la poursuite de l'offre étant caractérisée sur leur site et sur une plateforme professionnelle, et une astreinte pouvant atteindre 1 500 euros par jour est fixée pour l'avenir.

  3. 18 August 2026 Lepu Medical (Europe) Cooperatief U.A. v Occlutech (CoA, 18 August 2026) Appeal · UPC_CoA_87/2026 · appeal, first-instance number cited in the decision

What the record states

Nature of the act
Appeal
Outcome (Dhenne Avocats summary)
La cour d’appel confirme la liquidation d’astreinte de 58 800 euros : le blocage géographique des achats ne suffit pas, les offres maintenues sur le site de Lepu et sur une plateforme tierce caractérisant l’inexécution de l’injonction.
Appeal
Decision of the Court of Appeal (first instance cited: UPC_CFI_553/2025).
Instance
Court of Appeal decision.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 387 951Mentioned in the analysis (role not qualified)
Also mentioned in 4 other decision(s): Occlutech v Lepu Medical (Europe) Cooperatief (CFI, 20 May 2026) · Lepu Medical (Europe) Cooperatief U.A. v Occlutech (CoA, 6 May 2026) · Lepu Medical (Europe) Cooperat v Occlutech (CoA, 7 November 2025) · Occlutech v Lepu Medical Technology (Beijing) (CFI, 21 October 2025)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.